Objectives To assess the long‐term treatment efficacy of low‐dose‐rate (LDR) brachytherapy for the treatment of localized prostate cancer. Patients and Methods Cause‐of‐death annotation in our prospective database was supplemented with death certificate information obtained via an internal audit of...
The combination of brachytherapy and external beam radiation therapy (ProstRcision) has not been proven to be more effective than other established alternatives for the treatment of prostate cancer. Notes: Brachytherapy may be used in conjunction with surgery. Tumors close to critical structures that ...
Moreover, the dose gradient used improves organ at risks’ sparing. Conversely, a recent study has shown a decrease in the utilization rate of brachytherapy in the United States for cervical cancer patients, from 83% in 1988 to 58% in 2009 (p < 0.001), while brachytherapy is an ...
Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients. Late adverse events were significantly ...
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer...
Brachytherapy greatly shortens the duration of the treatment, in fact prostate cancer Brachytherapy can often take one and a half days rather than the 5-7 weeks of traditional radiation. What risk is involved in Brachytherapy treatment? Risks of this treatment approach include some incidence of impo...
The Physics of Modern Brachytherapy for Oncology Brachytherapy has become the modality of choice for several cancer localizations, minimizing the possibility of unacceptable risks for healthy tissues and ... D Baltas,L Sakelliou,N Zamboglou 被引量: 78发表: 2006年 加载更多来源...
Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study. This study was designed to estimate radiation-induced secondary cancer risks from high-dose-rate (HDR) brachytherapy and external radiotherapy for patients... B Lee,SH...
Abstract Importance Radiotherapy combined with androgen deprivation therapy (ADT) is a standard of care for high-risk prostate cancer. However, the interplay between radiotherapy dose and the required minimum duration of ADT is uncertain. Objective To determine the specific ADT duration threshold that ...
Purpose: To evaluate failure-free survival (FFS) for brachytherapy (BT) alone compared to external beam radiotherapy (EBRT) alone for Stage T1-2 Nx-No Mo patients over the same time period by a single community-based practice in the prostate-specific antigen (PSA) era. Materials and Methods...